$BKYI

BIO KEY INTERNATIONAL INC (BKYI) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. Item 5.07 Submission of Matters to a Vote of Security Holders. On September 3, 2026, BIO-key International, Inc. (the “ Company ”) convened its 2026 Annual Meeting of Stockholders (the “ Annual Meeting ”), which was adjourned and reconvened on Friday, October 2, 2026 and was adjo

BIO-key International (BKYI) stock rose 12.95% on October 28, 2026, driven by new Middle East government contracts and partnerships. The company secured seven Gulf customers in six months and partnered with Al Majlis Group. BKYI reported $5.94M revenue, negative profit margins, and $1.38M cash. Traders focus on momentum, not fundamentals.

BIO-key International (BKYI) announced a new deployment of its identity security solutions to a Middle East government's national security ecosystem. The engagement aims to strengthen identity security and access management across sensitive government systems, reducing reliance on traditional passwords. BIO-key's IAM technology centralizes identity and access controls, supporting a broader approach to identity security.

BIO-key International Inc. (NASDAQ: BKYI) stock surged 12.41% on October 23, 2026, driven by new Middle East government contracts and FIDO Alliance certification for its biometric security solutions. The company reported $5.94M in trailing revenue, an 81.3% gross margin, and a net loss of -$0.56 per share. BKYI's stock has seen significant volatility, with recent highs above $4.30 and a current range around $2.50–$3.25.

Cybersecurity stocks rose on Oct 22nd after critical PHP vulnerabilities were disclosed, affecting 70% of websites. Governments and companies urged immediate patches. Palo Alto Networks (PANW) and Zscaler (ZS) saw modest gains, while BIO-key International (BKYI) surged 30.48%. The Amplify Cybersecurity ETF (HACK) gained 0.42%.

BIO-key International (BKYI) announced a new Middle East government institution will use its biometric authentication solutions, including PortalGuard and fingerprint scanners, for secure, passwordless access. This is BIO-key's 7th customer in the Gulf region in 6 months, demonstrating growth in the area. The project was implemented with partner VaporVM.

Citigroup (NYSE:C) reported Q3 earnings of $2.85 per share, beating estimates. Bumble (NASDAQ:BMBL) surged 56% after a buyout deal. BIO-Key (NASDAQ:BKYI) rose 139% on a government security contract. Fermi (NASDAQ:FRMI) gained 21% on a credit agreement. Pershing Square (NYSE:PS) fell 11% after a downgrade. Cipher Digital (NASDAQ:CIFR) dropped 14% on a convertible notes offering. Syndax (NASDAQ:SNDX) declined 17% after a trial failure. Oil rose 0.4% to $94.13, while gold and silver fell.

The Dow Jones rose 100 points, while the NASDAQ and S&P 500 saw mixed results. Goldman Sachs (GS) reported Q3 earnings of $17.01 per share, beating estimates. Several stocks saw significant price changes, including JBDI, BKYI, and FLYE. Commodities and European/Asian markets also showed varied movements.

BIO-key International (BKYI) appointed Stephen Morrow as President of PortalGuard, its identity and access management platform, replacing retiring Mark Cochran. Morrow brings cybersecurity and enterprise sales experience. The company aims to expand enterprise adoption and partnerships, with its Passkey:YOU technology achieving FIDO certification.

BIO-key International Inc. (BKYI) stock surged 139.39% on news of a strategic partnership with Dubai-based Al Majlis Group, expanding into the UAE and Saudi Arabia. The company also secured FIDO Alliance Certification for its Passkey:YOU authenticator. BKYI reported $5.9M in revenue, negative profit margins, and a current ratio of 1.3. Traders are watching for execution on new contracts and revenue growth.